ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VAL Valirx Plc

3.45
0.00 (0.00%)
Last Updated: 07:31:42
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.45 3.40 3.50 3.45 3.45 3.45 27,591 07:31:42
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.32 3.11M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.45p. Over the last year, Valirx shares have traded in a share price range of 3.45p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £3.11 million. Valirx has a price to earnings ratio (PE ratio) of -1.32.

Valirx Share Discussion Threads

Showing 18501 to 18523 of 29350 messages
Chat Pages: Latest  742  741  740  739  738  737  736  735  734  733  732  731  Older
DateSubjectAuthorDiscuss
23/9/2020
14:10
VAL201 inhibits the growth of tumour cells, suppressing tumour growth
jusjusjus
23/9/2020
14:01
Missed this as an investment but as I have prostate cancer under surveillance,results will be interesting.What is it supposed to do?
trewsa
23/9/2020
13:30
What ready for the usual afternoon/close push up you mean.
412069
23/9/2020
13:26
Are they back from lunch yet
guss
23/9/2020
13:20
Easy another 30% rise before next week possible.
412069
23/9/2020
12:58
Now he is under 3% he can just feed the market if he wishes without notifying.
tburns
23/9/2020
12:41
https://www.proactiveinvestors.co.uk/companies/amp/news/909236ValiRx says its treatment had a "clear impact on patients with prostate cancer"2019-12-16 07:23:00The drug developer was at pains to stress this was only a very preliminary inference from the data measuring prostate-specific antigens and supported by tumour imaginValiRx PLC - ValiRx PLC (LON:VAL) said the initial feedback from a phase I/II study of VAL201 showed the treatment had a "clear impact on patients with prostate cancer".The drug developer was at pains to stress this was only a very preliminary inference from the data measuring prostate-specific antigens and supported by tumour imaging.ValiRx went on to confirm VAL201 was safe, with a "high degree of tolerability".According to a study by Bristol University, prostate cancer is the most common form of the disease in men in the UK. Worldwide, meanwhile, there were an estimated 1.3mln new cases last year."I look forward to regulatory approval of the trial data being speedily reached and the opportunity of potentially demonstrating that VAL201 can address this widespread and often fatal disease in men," said ValiRx chief executive, Dr Satu Vanikka.The results, along with a full statistical and scientific analysis, will be submitted to the drug regulator after which they will be made publicly available, the company said. No timeline was given.In the meantime, the preliminary observations are expected to be presented at cancer conferences.
h2owater
23/9/2020
12:41
RNS with Bown's sell from yesterday (should have waited until today!)
jusjusjus
23/9/2020
12:29
The problem they have is that everytime they try and drop it peeps buy into it. They would be better off just letting it go and allowing it to find its own level pre-results next week imho
tburns
23/9/2020
12:19
THey are widening the spread to try and hold us under 50
guss
23/9/2020
12:16
Look like 80p is the next stop :)
deanmatlazin
23/9/2020
12:11
How many time do i have to say it Not enough shares to go around, with sellers not selling fast enough.
412069
23/9/2020
12:07
And a minute later over 50p . Amazing :-)
jungmana
23/9/2020
12:07
Crash through
guss
23/9/2020
12:07
That is 50p well and truly gone GLA
tburns
23/9/2020
12:06
In auction at 50p, go on my son!
tburns
23/9/2020
12:06
50p will be cracked with ease today, around 55p finish, this closes very strongly.
412069
23/9/2020
12:04
I hope they hold the results until the very last minute as this can continue to run up pre results and could plummet post results, even on good news as some have over ambitious expectations. Even if no plummet, it would be good to launch from a higher platform.
guss
23/9/2020
12:04
50p may prove hard to crack today. Psychology at play with that round number.Have taken some off the table. Will hold the rest for results. Good luck to us
jungmana
23/9/2020
11:58
Stoneme today’s RNS confirms your optimism:

“ it still expects to receive and notify the headline VAL 201 trial results by 30 September 2020 as stated in the half year results notified on 7 September 2020, ”

uknighted
23/9/2020
11:55
It is not like we need much patience . . Days away at most
stoneme
23/9/2020
11:50
Suzy keeps to her word..
When the data is ready they will release immediately.. this could be anytime..
Not only 07:00am but ANY time through trading day...
Be warned..if you sell... lockout!
DYOR

jasonpugh
23/9/2020
11:39
I think it is about to go thrusting past 50p. Buying is relentless, and no sellers
stoneme
Chat Pages: Latest  742  741  740  739  738  737  736  735  734  733  732  731  Older

Your Recent History

Delayed Upgrade Clock